Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

An 80-year-old woman's severe hair loss was caused by a hormone-secreting ovarian tumor.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Taking thyroid medication reduced the patient's pituitary gland swelling and improved her symptoms.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

The E2 protein affects gene activity in hair follicles of mice.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

ERG increases SOX9, promoting prostate cancer growth and invasion.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Leydig cell tumors in the ovary can cause high testosterone and male traits in postmenopausal women but are treatable with surgery.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.